FONAR Corporation (FONR) Stock Analysis

FONAR Corporation (FONR) Healthcare & Pipeline Overview

FONAR Corporation (FONR) is a medical device company specializing in MRI technology, particularly its unique Upright MRI. Operating through medical equipment and physician management segments, FONAR distinguishes itself with weight-bearing MRI capabilities, serving private diagnostic centers and hospitals within the broader healthcare sector.

What Is the Investment Thesis for FONR?

FONAR Corporation presents a compelling, albeit niche, investment opportunity within the medical devices sector. The company's unique Upright MRI technology offers a distinct advantage, allowing for weight-bearing scans that traditional MRIs cannot provide. With a market capitalization of $118M and a P/E ratio of 18.90, FONAR demonstrates profitability, supported by a 7.1% profit margin and a 40.8% gross margin. Growth catalysts include expanding the installed base of Upright MRI scanners and increasing the utilization of its physician management and diagnostic services. However, potential risks include competition from larger medical device companies and the capital-intensive nature of developing and marketing advanced MRI technology. Investors should monitor the company's ability to maintain its technological edge and expand its market presence.

Based on FMP financials and quantitative analysis

FONR Key Highlights

Market capitalization of $118M reflects the company's current valuation in the medical device market.

• P/E ratio of 18.90 indicates the price investors are willing to pay for each dollar of FONAR's earnings.
• Profit margin of 7.1% demonstrates the company's ability to generate profit from its revenue.
• Gross margin of 40.8% highlights the profitability of FONAR's core business activities.
• Beta of 0.99 suggests that FONAR's stock price is slightly less volatile than the overall market.

Who Are FONR's Competitors?

FONR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are FONR's Key Strengths?

Unique Upright MRI technology.

• Established presence in the MRI market.
• Comprehensive physician management services.
• Experienced management team.

What Are FONR's Weaknesses?

Smaller market share compared to larger competitors.

• Limited geographic diversification.
• Dependence on MRI scanner sales.
• Capital-intensive research and development.

What Could Drive FONR Stock Higher?

Expansion of Upright MRI technology into new clinical applications.

• Increased utilization of physician management and diagnostic services.
• Potential partnerships with healthcare providers and research institutions.
• Regulatory approvals for new MRI technologies and applications.

What Are the Key Risks for FONR?

Competition from larger medical device companies with greater resources.

• Technological advancements rendering existing MRI technology obsolete.
• Changes in healthcare regulations and reimbursement policies.
• Economic downturns affecting healthcare spending and capital investments.

What Are the Growth Opportunities for FONR?

• Expansion of Upright MRI Technology: FONAR has a significant growth opportunity in expanding the adoption of its Upright MRI technology. The unique weight-bearing capabilities of this technology offer advantages in diagnosing musculoskeletal and neurological conditions. The market for specialized MRI solutions is growing, driven by the increasing demand for more accurate and comprehensive diagnostic imaging. By targeting specific clinical applications and highlighting the benefits of Upright MRI, FONAR can increase its market share and drive revenue growth. This expansion could see increased adoption within 3-5 years.
• Geographic Expansion: FONAR can pursue geographic expansion by targeting new markets both domestically and internationally. While the company currently has a presence in the United States, there is potential to expand into other regions with growing healthcare infrastructure and demand for advanced diagnostic imaging. By establishing partnerships with local distributors and healthcare providers, FONAR can gain access to new markets and increase its global footprint. This expansion could unfold over the next 2-4 years, contingent on regulatory approvals and market entry strategies.
• Strategic Partnerships and Acquisitions: FONAR can explore strategic partnerships and acquisitions to expand its product portfolio and market reach. By partnering with complementary technology providers or acquiring smaller companies with innovative solutions, FONAR can enhance its offerings and strengthen its competitive position. These partnerships can provide access to new technologies, distribution channels, and customer segments, accelerating growth and diversification. Strategic moves could materialize within the next 1-3 years.
• Increased Utilization of Physician Management Services: FONAR's physician management and diagnostic services segment presents a growth opportunity by increasing the utilization of these services among existing and new clients. By offering comprehensive solutions that streamline administrative tasks, improve billing and collection efficiency, and enhance practice growth, FONAR can attract more physician practices and increase recurring revenue. This growth can be realized within the next 1-2 years through targeted marketing and service enhancements.
• Technological Advancements and Innovation: Continued investment in research and development is crucial for FONAR to maintain its competitive edge and drive future growth. By focusing on technological advancements and innovation, FONAR can develop new MRI solutions and enhance the capabilities of its existing products. This includes exploring new imaging techniques, improving image quality, and developing more user-friendly interfaces. Innovation will be an ongoing process, with potential breakthroughs and product enhancements occurring over the next 3-5 years.

What Are FONR's Competitive Advantages?

• Proprietary Upright MRI technology provides a unique competitive advantage.
• Established relationships with hospitals and diagnostic centers.
• Comprehensive suite of physician management services enhances customer loyalty.
• Intellectual property protection through patents and trademarks.

What Does FONR Do?

Founded in 1978 and based in Melville, New York, FONAR Corporation has established itself as a key player in the magnetic resonance imaging (MRI) market. The company's core business revolves around the research, development, production, and marketing of MRI scanners designed for the detection and diagnosis of human diseases. FONAR's flagship product is its Upright MRI scanner, a unique technology that allows patients to be scanned in weight-bearing positions, such as standing, sitting, bending, or lying down. This capability provides clinicians with valuable diagnostic information that may not be available with traditional MRI systems. FONAR operates through two primary segments: the Medical Equipment segment, which focuses on the sale and service of its MRI scanners, and the Physician Management and Diagnostic services segment. In addition to manufacturing and selling MRI equipment, FONAR offers a comprehensive suite of non-medical management services to physician practices. These services include administrative support, billing and collection, credentialing, contract negotiation, compliance consulting, IT services, human resources management, medical record storage, office space, equipment maintenance, accounting, and practice growth and marketing strategies. The company owns and operates five diagnostic imaging facilities in Florida and manages 39 MRI scanning facilities, with 25 located in New York and 14 in Florida. FONAR markets its MRI scanners to a diverse customer base, including private diagnostic imaging centers and hospitals throughout the United States. With a history spanning over four decades, FONAR continues to innovate in the MRI technology space, focusing on providing advanced diagnostic solutions to healthcare providers.

What Products and Services Does FONR Offer?

• Develops and manufactures MRI scanners for medical diagnostics.
• Offers Upright MRI technology, allowing patients to be scanned in weight-bearing positions.
• Provides non-medical management services to physician practices.
• Operates diagnostic imaging facilities.
• Manages MRI scanning facilities.
• Markets MRI scanners to private diagnostic imaging centers and hospitals.

How Does FONR Make Money?

• Sales of MRI scanners to hospitals and diagnostic centers.
• Revenue from physician management and diagnostic services.
• Operation of diagnostic imaging facilities.
• Service and maintenance contracts for MRI equipment.

What Industry Does FONR Operate In?

FONAR Corporation operates within the medical devices industry, a segment characterized by continuous innovation and technological advancements. The MRI market is competitive, with larger players like Siemens Healthineers and GE Healthcare dominating the landscape. FONAR differentiates itself with its Upright MRI technology, catering to a specific niche within the broader MRI market. The industry is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in imaging technology. The global MRI market is expected to continue growing, presenting opportunities for FONAR to expand its market share.

Who Are FONR's Key Customers?

• Private diagnostic imaging centers.
• Hospitals.
• Physician practices.
• Healthcare providers.

FONAR Corporation Financial Trajectory

FONAR Corporation (FONR) reported $26.5M in revenue for Mar 2026, reflecting 3.6% growth compared to the prior quarter. The company recorded net income of $1.6M, with diluted EPS of $0.26. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, FONR averaged $0.26 in diluted EPS.

Company Profile

FONAR Corporation operates in the Medical - Equipment & Services industry within the Healthcare sector. It is headquartered in Melville, US. The company is led by CEO Timothy R. Damadian. FONR has traded publicly since 1981.

How FONAR Corporation Is Valued

FONAR Corporation carries a market capitalization of $118M, placing it in the micro-cap category.

Return on equity for FONAR Corporation stands at 3.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.1%, showing how much profit it generates from its asset base. FONR trades at a trailing price-to-earnings ratio of 18.90, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 3.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 9.18 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.7%, the inverse of the P/E and a quick read on earnings relative to price.

FONAR Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.67 places it in the grey zone, a middle ground that warrants monitoring.

Over the past six months, FONAR Corporation insiders filed 6 SEC Form 4 transactions — 0 sales and 6 purchases. On net that is roughly 554K shares acquired (about $10.6M) — insiders putting money in tends to read as conviction.

FONR Financials

FONR Latest News

FONAR Corporation Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources